ArticleHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2025
Collective efficacy: A protective factor for sexual minority men during the U.S. mpox outbreak.
Article in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesCollective efficacy is an understudied potential protective factor for health behavior change. This study extends previous research on HIV and COVID-19 infection to test associations with mpox vaccination and symptoms of depression and anxiety among sexual minority men during the mpox outbreak.
methodBetween July 28, 2022 and September 22, 2022, adult cisgender sexual minority men (n = 2,614) were recruited from social networking applications and completed a cross-sectional online survey that assessed collective efficacy (united action), mpox vaccination, and symptoms of anxiety and depression.
resultsIn multivariable regression models, united action was positively associated with having received at least one dose of the mpox vaccine (OR = 1.025, p = .04) and negatively associated with anxiety (β = -.055, p < .004) and depression (β = -.037, p = .05) above and beyond disease-related cognition and behavioral risk factors (sex with casual partners and substance use).
conclusionThese findings suggest that perceptions of community agency to overcome health threats may be associated with individual health benefits. Clinically, these results suggest interventions that activate or develop community-level capacity to cope or respond to disease outbreaks may be useful public health strategies to mitigate infection risk as well as some mental health challenges among members of communities at high risk of infection. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.